Evidence map›Paper›PMID 23649044›Full record

ArticleClinical immunology (Orlando, Fla.)2013

Characterization of direct radiation-induced immune function and molecular signaling changes in an antigen presenting cell line.

Jennifer J Parker, Jennifer C Jones, Samuel Strober, Susan J Knox

Open access · greenAbstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. When DNA-damage responses meet innate and adaptive immunity.Cellular and molecular life sciences : CMLS · 2024
    Review
  3. Article
  4. Monocyte programming by cancer therapy.Frontiers in immunology · 2022
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Biological effects of radiation on cancer cells.Military Medical Research · 2018
    Review
  15. Review
  16. Review
  17. Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination.Clinical cancer research : an official journal of the American Association for Cancer Research · 2016
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jennifer J ParkerDepartment of Chemical and Systems Biology, Stanford University, Stanford, CA, USA.
Jennifer C Jones
Samuel Strober
Susan J Knox
Stanford University · US

Funding

Novel Combinations of Radiation and ImmunotherapyZIABC011503 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI JONES, JENNIFER · 2013 to 2025
$5.3M
Radiotherapy as Immunotherapy of TumorsR01CA163441 · NCI · STANFORD UNIVERSITY · PI STROBER, SAMUEL · 2012 to 2016
$2.2M
NCI NIH HHS IR01-CA163441NCI NIH HHS R01 CA163441
6 · The paper itself

Abstract

Radiation therapy is a widely used cancer treatment and pre-transplantation conditioning regimen that has the potential to influence anti-tumor and post-transplantation immune responses. Although conventionally fractionated radiation doses can suppress immune responses by depleting lymphocytes, single high doses of local tumor radiation can enhance immune responses. Using phospho-flow cytometry analysis of a human monocytic cell line, we identified novel radiation-induced changes in the phosphorylation state of NFκB family members known in other cell types to maintain and regulate immune function. These phosphorylation changes were p53 independent, but were strongly dependent upon ATM activation due to DNA damage. We found that radiation promotes the activation and APC functional maturation through phosphorylation of NFκB Essential Modulator (NEMO). Our results and the analytic methods are especially well suited to the study of functional changes in APC when radiation is used for immune modulation in clinical protocols.

Indexed as

Gamma RaysAntigen-Presenting CellsCell Growth ProcessesFlow CytometryHumansI-kappa B KinaseNF-kappa BPhosphorylationProtein Serine-Threonine KinasesSignal TransductionTumor Suppressor Protein p53U937 CellsI-kappa B KinaseIKBKG protein, humanNF-kappa BProtein Serine-Threonine KinasesTumor Suppressor Protein p53

Identifiers

PMID23649044
PMCPMC4045494
OpenAlexW2096477282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.